Crossmark

Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer

Crossref DOI link: https://doi.org/10.1038/srep29382

Published Online: 2016-07-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Jing

Guo, Jiawei

Chen, Zhi

Wang, Jieqiong

Liu, Mingyao

Pang, Xiufeng
License Information

Text and Data Mining valid from 2016-07-08

Version of Record valid from 2016-07-08
More Information

Article History

Received: 18 April 2016

Accepted: 17 June 2016

First Online: 8 July 2016

Competing interests

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below